Advances in Heart Diseases: Molecular Pathogenesis, Biomarkers and Therapies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 403
Special Issue Editor
Interests: biomarkers; heart failure; ischemic heart disease; preserved ejection fraction; cardiology; fibrosis; inflammation; non-coding RNA
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In recent decades, significant advancements have been achieved in the diagnosis and management of heart diseases, along with an enhanced understanding of their molecular pathogenesis. These developments have been instrumental in leveraging specific biomarkers to guide increasingly innovative therapeutic interventions. Novel insights into the molecular pathways implicated in disease progression have emerged.
Concurrently, the identification and validation of biomarkers have transformed diagnostic and prognostic approaches, facilitating early detection, streamlined management, and personalized treatment strategies. Biomarkers such as troponins, BNPs, and non-coding RNAs have emerged as invaluable tools in clinical practice, furnishing clinicians with crucial information for patient management. Moreover, therapeutic interventions have undergone substantial evolution, encompassing traditional cardiac pharmacological agents alongside novel pharmacological and interventional therapies, as well as comorbidity treatments, aimed at alleviating disease burden and enhancing patient outcomes.
In this Special Issue, we will explore the strides in molecular understanding, biomarker discovery, and therapeutic innovation, promising a brighter future in the battle against heart disease.
Dr. Nadia Aspromonte
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart diseases
- biomarkers
- molecular pathways
- personalized medicine
- interventional therapies
